SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001193125-17-197124
Filing Date
2017-06-07
Accepted
2017-06-07 16:48:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B2 d404406d424b2.htm 424B2 503353
2 GRAPHIC g404406g61r59.jpg GRAPHIC 48366
  Complete submission text file 0001193125-17-197124.txt   571202
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-200452 | Film No.: 17897747
SIC: 2834 Pharmaceutical Preparations